These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 27391622)

  • 1. CHAMP Symposium on Androgens, Anabolic Steroids, and Related Substances: What We Know and What We Need to Know.
    Givens ML; Deuster PA; Kupchak BR
    Mil Med; 2016 Jul; 181(7):680-6. PubMed ID: 27391622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anabolic-androgenic steroids: use and abuse in pediatric patients.
    Kerr JM; Congeni JA
    Pediatr Clin North Am; 2007 Aug; 54(4):771-85, xii. PubMed ID: 17723876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of androgenic and anabolic steroids on the sebaceous gland in power athletes.
    Király CL; Alén M; Rahkila P; Horsmanheimo M
    Acta Derm Venereol; 1987; 67(1):36-40. PubMed ID: 2436412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abuse of anabolic androgenic steroids and related substances in sport and exercise.
    Bahrke MS; Yesalis CE
    Curr Opin Pharmacol; 2004 Dec; 4(6):614-20. PubMed ID: 15525553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Anabolic 500 survey: characteristics of male users versus nonusers of anabolic-androgenic steroids for strength training.
    Ip EJ; Barnett MJ; Tenerowicz MJ; Perry PJ
    Pharmacotherapy; 2011 Aug; 31(8):757-66. PubMed ID: 21923602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of anabolic steroid use and associated factors among body-builders in Hamadan, West province of Iran.
    Razavi Z; Moeini B; Shafiei Y; Bazmamoun H
    J Res Health Sci; 2014; 14(2):163-6. PubMed ID: 24728754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ANDROGENIC AND ANABOLIC HORMONES: A NEW GROUP OF SUBSTANCES STIMULATING ENDOGENOUS ASCORBIC ACID SYNTHESIS IN THE RAT.
    VANHA-PERTTULA TP
    Experientia; 1963 Aug; 19():426-7. PubMed ID: 14084066
    [No Abstract]   [Full Text] [Related]  

  • 8. The metabolic effects of certain anabolic steroids.
    ANDERSON IA
    Acta Endocrinol Suppl (Copenh); 1961; 39(Suppl 63)():54-77. PubMed ID: 13861231
    [No Abstract]   [Full Text] [Related]  

  • 9. An assay for anabolic steroids employing metabolic balance in the monkey: the anabolic activity of fluoxymesterone and its 11-keto analogue.
    STUCKI JC; FORBES AD; NORTHAM JI; CLARK JJ
    Endocrinology; 1960 Apr; 66():585-98. PubMed ID: 13835390
    [No Abstract]   [Full Text] [Related]  

  • 10. Women in Combat: Summary of Findings and a Way Ahead.
    Tepe V; Yarnell A; Nindl BC; Van Arsdale S; Deuster PA
    Mil Med; 2016 Jan; 181(1 Suppl):109-18. PubMed ID: 26741909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current concepts in anabolic-androgenic steroids.
    Evans NA
    Am J Sports Med; 2004 Mar; 32(2):534-42. PubMed ID: 14977687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgenic-anabolic steroids and the Olympic Games.
    Fitch KD
    Asian J Androl; 2008 May; 10(3):384-90. PubMed ID: 18385900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Synthetic anabolic steroids].
    GOMEZ DE URIBE F
    Medicamenta (Madr); 1961 Nov; 13():203-9. PubMed ID: 13900057
    [No Abstract]   [Full Text] [Related]  

  • 14. Prolongation and potentiation of anabolic and androgenic effects of steroids; testosterone and methyl-androstenediol.
    SAKAMOTO W; GORDAN GS; EISENBERG E
    Proc Soc Exp Biol Med; 1951 Feb; 76(2):406-8. PubMed ID: 14827941
    [No Abstract]   [Full Text] [Related]  

  • 15. Identifying lympholytic and androgenic effects of androgenic steroids.
    Glick B; Rao DS; McDuffie FC
    Gen Comp Endocrinol; 1977 Jan; 31(1):133-7. PubMed ID: 832812
    [No Abstract]   [Full Text] [Related]  

  • 16. [Action mechanism of synthetic androgens].
    Matsumoto K; Namiki M
    Nihon Rinsho; 1994 Mar; 52(3):600-5. PubMed ID: 8164356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anabolic properties of ethylestrenol.
    OVERBEEK GA; DELVER A; de VISSER
    Acta Endocrinol (Copenh); 1962 May; 40():133-9. PubMed ID: 14482850
    [No Abstract]   [Full Text] [Related]  

  • 18. Testosterone and doping control.
    Saudan C; Baume N; Robinson N; Avois L; Mangin P; Saugy M
    Br J Sports Med; 2006 Jul; 40 Suppl 1(Suppl 1):i21-4. PubMed ID: 16799097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of the antithyrotoxic effects of a protein-anabolic testosterone derivative (1-methyl-delta1-androstenolone)].
    KRUESKEMPER HL; KESSLER FJ; HASSAN SH
    Klin Wochenschr; 1961 Oct; 39():1013-8. PubMed ID: 14459898
    [No Abstract]   [Full Text] [Related]  

  • 20. The history of the development of anabolic-androgenic steroids.
    Dotson JL; Brown RT
    Pediatr Clin North Am; 2007 Aug; 54(4):761-9, xi. PubMed ID: 17723875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.